Ocular manifestations of Graves' disease: therapeutic approaches.

Por Day, R. M.
Publicado em 1977

Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction.

Por Day, R M, Carroll, F D
Publicado em 1967

Cataract extraction after filtering procedures.

Por Regan, E F, Day, R M
Publicado em 1970

A 13C-NMR study of the role of Asn-155 in stabilizing the oxyanion of a subtilisin tetrahedral adduct.

Por O'connell, T P, Day, R M, Torchilin, E V, Bachovchin, W W, Malthouse, J G
Publicado em 1997

Impaired neutrophil chemotaxis in Crohn’s disease relates to reduced production of chemokines and can be augmented by granulocyte-colony stimulating factor

Por HARBORD, M. W. N., MARKS, D. J. B., FORBES, A., BLOOM, S. L., DAY, R. M., SEGAL, A. W.
Publicado em 2006

The efficacy and safety of apremilast, etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis: 52‐week results from a phase IIIb, randomized, placebo‐controlle...

Por Reich, K., Gooderham, M., Green, L., Bewley, A., Zhang, Z., Khanskaya, I., Day, R.M., Goncalves, J., Shah, K., Piguet, V., Soung, J.
Publicado no J Eur Acad Dermatol Venereol (2016)

Rapid magnetic cell delivery for large tubular bioengineered constructs

Por Gonzalez-Molina, J., Riegler, J., Southern, P., Ortega, D., Frangos, C. C., Angelopoulos, Y., Husain, S., Lythgoe, M. F., Pankhurst, Q. A., Day, R. M.
Publicado em 2012